Clinical Trials in Salt Lake City

Showing 2241-2260 of 14,325 trials

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

NCT03801434

This phase II trial studies how well ruxolitinib works in treating patients with hypereosinophilic syndrome or primary eosinophilic disorders.

BCR-JAK2 Fusion Protein ExpressionBlasts 20 Percent or Less of Peripheral Blood White CellsBlasts More Than 5 Percent of Bone Marrow Nucleated Cells+9 more

William Shomali10 participantsStarted Nov 2019

Palo Alto, California, United States • Portland, Oregon, United States • Salt Lake City, Utah, United States +1 more locations

Enrolling By Invitation< 1 mile

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

NCT05506423

This observational study will enroll adults with open angle glaucoma (OAG) who had surgery to reduce intraocular pressure (IOP) using the CycloPen Micro-Interventional System. Consenting participants will be followed for 24 months after their surgery. Data regarding IOP, use of glaucoma medications, and any side effects related to the surgery will be collected from participants' preoperative examination, their surgery, and postoperative examinations.

Open Angle Glaucoma

Iantrek, Inc.300 participantsStarted Aug 2022

Newport Beach, California, United States • Cape Coral, Florida, United States • DeLand, Florida, United States +13 more locations

Ruxolitinib in Treating Patients With Hypereosinophilic Syndrome or Primary Eosinophilic Disorders

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes

Find Trials by Condition in Salt Lake City

Single and Multiple Ascending Dose Study and Food Effect Study for AG181

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B

A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma.

Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients

Phase 2b/3 Study to Assess ABP-671 a Novel URAT1 Inhibitor in Participants With Gout

Long-term Assessment of the Safety and Performance of the NuVasive Simplify Disc

Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)

Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

A Study of Axicabtagene Ciloleucel in Participants With Relapsed/Refractory Indolent Non-Hodgkin Lymphoma

Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)

Capivasertib+Paclitaxel as First Line Treatment for Patients With Locally Advanced or Metastatic TNBC

SP Thoracic IDE Study

Gene Therapy for Cardiomyopathy Associated With Friedreich's Ataxia

Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA

A Study to Evaluate Patient Satisfaction With the Overall Face and Neck Appearance After Combined Treatment of OnabotulinumtoxinA, JUVÉDERM® Products, KYBELLA, CoolSculpting Elite and SkinMedica Products

A Study of VRC07-523LS, PGT121.414.LS, and PGDM1400LS Broadly Neutralizing Monoclonal Antibodies Given Intravenously in Adult Participants Without HIV

Pembrolizumab With Carboplatin Compared to Carboplatin Alone in Breast Cancer Patients With Chest Wall Disease